Aspirin

WHO essential drug

UNDER REVIEW (April 2017)

Mechanism of Action:

Non-selective cyclo-oxygenase (COX) inhibitor&#059; antiinflammatory antipyretic analgesic. Inhibition of COX reduces the production of proinflammatory eicosanoids (prostalandins and thromboxanes). Certain PGs (PGE2 and PGI2) sensitize the nociceptive terminals to endogenous algogens, so by reducing the production of these prostanoids, aspirin removes the sensitizing action and so causes analgesia. PGs and TXs are formed de novo in the periphery and CNS (including spinal cord) – they are not stored in cells.

Lecture and CAL materials:


Drug specifics

Alternative drug name Acetylsalicylic acid (ASA)
Effects

Antiinflammatory Analgesics: Reduces pain and inflammation by reducing inflammatory actions of eicosanoids, particularly the prostanoid PGE2 - COX-2 is upregulated in inflamed tissue. Antipyretic in fever.

Antiplatelet agents:

Adverse actions

Antiinflammatory Analgesics: GI disturbance - nausea, dyspepsia. Skin reactions, itching; Chronic = risk of peptic ulcer from inhibition og COX-1; inhibit thromboxane synthesis increasing bleeding by preventing platelet agreggation; induces asthma in many asthmatics via bronchospasm; tinnitus in high doses, also confusion, hyperexia (normally acts as antipyretc in febrile states) and acid-base disturbance leading to hyperventilation, reduced renal blood flow and glomerular filtration rate (COX-2 promotes production of vasodilator PGE2 - inhibition of the enzyme stops this), Reye's syndrome in under 16s. see eBNF .

Antiplatelet agents:

Dose

Antiinflammatory Analgesics: see eBNF

Antiplatelet agents:

Interactions

Antiinflammatory Analgesics: see eBNF

Antiplatelet agents:

Contraindications not specified
Comments

Antiinflammatory Analgesics: Indometacin (indomethacin) is a methylated indole derivative and a member of the arylalkanoic acid class of NSAIDs, which includes diclofenac. It is a non-selective COX inhibitor.

Antiplatelet agents:

Contributors